RYVU Therapeutics S.A.
RVU | WAR
Overview
Corporate Details
- ISIN(s):
- PLSELVT00013 (+2 more)
- LEI:
- 2594003WO9Q9HHAFL031
- Country:
- Poland
- Address:
- Kraków Leona Henryka Sternbacha 2, 30-394 Kraków
- Website:
- https://ryvu.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Ryvu Therapeutics is a clinical-stage drug discovery and development company focused on novel small molecule therapies that address emerging targets in oncology. Ryvu Therapeutics was founded in 2007 and currently employs 230 scientists, including 80 Ph.Ds. Ryvu was previously known as Selvita, until renamed to Ryvu Therapeutics after spin out of the services segment. The company is headquartered in Kraków, Poland. Ryvu Therapeutics is developing therapeutics that address clinical limitations of current treatments in oncology. Our work is defined by deep scientific knowledge, organizational efficiency, and a high throughput discovery engine platform. Our lead candidate, RVU120, is a selective CDK8/CDK19 kinase inhibitor with potential for development in hematological malignancies and solid tumors, currently in Phase 1b study for the treatment of acute myeloid leukemia and myelodysplastic syndrome, and Phase I/II for the treatment of r/r metastatic or advanced solid tumors.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-12 18:02 |
Directors' Dealings
Powiadomienie Fundacja Rodzinna Rodziny Wesołowskich
|
Polish | 8.9 KB | |
| 2025-06-12 18:02 |
Directors' Dealings
Powiadomienie Augebit
|
Polish | 8.9 KB | |
| 2025-06-12 18:02 |
Regulatory News Service
Zawiadomienia od osób blisko związanych z osobą pełniącą obowiązki zarządcze w …
|
English | 1.4 KB | |
| 2025-06-12 18:02 |
Regulatory News Service
Zawiadomienia od osób blisko związanych z osobą pełniącą obowiązki zarządcze w …
|
Polish | 850 bytes | |
| 2025-06-12 08:14 |
Regulatory News Service
Załącznik_Prezentacja_EN
|
Polish | 5.7 MB | |
| 2025-06-12 08:14 |
Regulatory News Service
Załącznik_Prezentacja_PL
|
Polish | 5.7 MB | |
| 2025-06-12 08:14 |
Regulatory News Service
Dane dotyczące RVU120 prezentowane podczas Kongresu Europejskiego Towarzystwa …
|
English | 7.3 KB | |
| 2025-06-12 08:14 |
Regulatory News Service
Dane dotyczące RVU120 prezentowane podczas Kongresu Europejskiego Towarzystwa …
|
Polish | 7.9 KB | |
| 2025-06-09 18:47 |
Directors' Dealings
Zawiadomienie Augebit
|
Polish | 8.9 KB | |
| 2025-06-09 18:47 |
Directors' Dealings
Zawiadomienie Fundacja Rodziny Wesołowskich
|
Polish | 8.9 KB | |
| 2025-06-09 18:47 |
Regulatory News Service
Zawiadomienia od osób blisko związanych z osobą pełniącą obowiązki zarządcze w …
|
English | 1.4 KB | |
| 2025-06-09 18:47 |
Regulatory News Service
Zawiadomienia od osób blisko związanych z osobą pełniącą obowiązki zarządcze w …
|
Polish | 849 bytes | |
| 2025-05-29 09:20 |
Board/Management Change
Bio- Justyna Żółtek
|
Polish | 84.8 KB | |
| 2025-05-29 09:20 |
Board/Management Change
Zmiany w Zarządzie Ryvu Therapeutics S.A. / Changes in the Management Board of …
|
English | 1.7 KB | |
| 2025-05-29 09:20 |
Board/Management Change
Zmiany w Zarządzie Ryvu Therapeutics S.A. / Changes in the Management Board of …
|
Polish | 1.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
AstraZeneca PLC | United Kingdom | AZN | |
|
Basilea Pharmaceutica AG | Switzerland | BSLN | |
|
Bayer AG | Germany | BAY | |
|
Biogened Spolka Akcyjna | Poland | BGD | |
|
Biotika A.S. | Slovakia | BSL | |
|
Bio Vitos Pharma AB | Sweden | BIOVIT | |
|
BOIRON | France | BOI | |
|
Bonyf N.V. | Belgium | MLBON | |
|
Bosnalijek d.d. Sarajevo | Bosnia and Herzegovina | BSNL | |
|
Calliditas Therapeutics | Sweden | CALTX |